The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Blood Plasma-Global Market Insights and Sales Trends 2024
Synopsis
Colloids (blood plasma) are the substances of expanding the circulating blood volume, which mainly contain albumin type, gelatin type, dextran type and hydroxyethyl starch type.
Colloids (Blood Plasma) can be applied for extensive burns, massive blood or plasma loss and hypovolemic shock. In this report, we calculate colloids (blood plasma) preparations, which is produced by albumin, gelatin, dextran and hydroxyethyl starch.
The global Blood Plasma market size is expected to reach US$ 478.8 million by 2029, growing at a CAGR of 2.3% from 2023 to 2029. The market is mainly driven by the significant applications of Blood Plasma in various end use industries. The expanding demands from the Hospitals and Clinics, Research Laboratories and Academic Institutions,, are propelling Blood Plasma market. Immunoglobulin, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Albumin segment is estimated at % CAGR for the next seven-year period.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Blood Plasma, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Blood Plasma market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Blood Plasma market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Blood Plasma sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Blood Plasma covered in this report include Baxter International, CSL, Grifols, Octapharma, ADMA Biologics, Cerus Corp, Sanquin, Shanghai Raas and TCS Biosciences, etc.
The global Blood Plasma market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Baxter International
CSL
Grifols
Octapharma
ADMA Biologics
Cerus Corp
Sanquin
Shanghai Raas
TCS Biosciences
Global Blood Plasma market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Blood Plasma market, Segment by Type:
Immunoglobulin
Albumin
Protease Inhibitors
Coagulation Factor Concentrates
Others
Global Blood Plasma market, by Application
Hospitals and Clinics
Research Laboratories
Academic Institutions
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Blood Plasma manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Blood Plasma in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Colloids (blood plasma) are the substances of expanding the circulating blood volume, which mainly contain albumin type, gelatin type, dextran type and hydroxyethyl starch type.
Colloids (Blood Plasma) can be applied for extensive burns, massive blood or plasma loss and hypovolemic shock. In this report, we calculate colloids (blood plasma) preparations, which is produced by albumin, gelatin, dextran and hydroxyethyl starch.
The global Blood Plasma market size is expected to reach US$ 478.8 million by 2029, growing at a CAGR of 2.3% from 2023 to 2029. The market is mainly driven by the significant applications of Blood Plasma in various end use industries. The expanding demands from the Hospitals and Clinics, Research Laboratories and Academic Institutions,, are propelling Blood Plasma market. Immunoglobulin, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Albumin segment is estimated at % CAGR for the next seven-year period.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Blood Plasma, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Blood Plasma market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Blood Plasma market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Blood Plasma sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Blood Plasma covered in this report include Baxter International, CSL, Grifols, Octapharma, ADMA Biologics, Cerus Corp, Sanquin, Shanghai Raas and TCS Biosciences, etc.
The global Blood Plasma market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Baxter International
CSL
Grifols
Octapharma
ADMA Biologics
Cerus Corp
Sanquin
Shanghai Raas
TCS Biosciences
Global Blood Plasma market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Blood Plasma market, Segment by Type:
Immunoglobulin
Albumin
Protease Inhibitors
Coagulation Factor Concentrates
Others
Global Blood Plasma market, by Application
Hospitals and Clinics
Research Laboratories
Academic Institutions
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Blood Plasma manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Blood Plasma in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Blood Plasma Market Overview
1.1 Blood Plasma Product Overview
1.2 Blood Plasma Market Segment by Type
1.2.1 Immunoglobulin
1.2.2 Albumin
1.2.3 Protease Inhibitors
1.2.4 Coagulation Factor Concentrates
1.2.5 Others
1.3 Global Blood Plasma Market Size by Type
1.3.1 Global Blood Plasma Market Size Overview by Type (2018-2029)
1.3.2 Global Blood Plasma Historic Market Size Review by Type (2018-2023)
1.3.3 Global Blood Plasma Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Blood Plasma Sales Breakdown by Type (2018-2023)
1.4.2 Europe Blood Plasma Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Blood Plasma Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Blood Plasma Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Blood Plasma Sales Breakdown by Type (2018-2023)
2 Global Blood Plasma Market Competition by Company
2.1 Global Top Players by Blood Plasma Sales (2018-2023)
2.2 Global Top Players by Blood Plasma Revenue (2018-2023)
2.3 Global Top Players by Blood Plasma Price (2018-2023)
2.4 Global Top Manufacturers Blood Plasma Manufacturing Base Distribution, Sales Area, Product Type
2.5 Blood Plasma Market Competitive Situation and Trends
2.5.1 Blood Plasma Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Blood Plasma Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Blood Plasma as of 2022)
2.7 Date of Key Manufacturers Enter into Blood Plasma Market
2.8 Key Manufacturers Blood Plasma Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Blood Plasma Status and Outlook by Region
3.1 Global Blood Plasma Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Blood Plasma Historic Market Size by Region
3.2.1 Global Blood Plasma Sales in Volume by Region (2018-2023)
3.2.2 Global Blood Plasma Sales in Value by Region (2018-2023)
3.2.3 Global Blood Plasma Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Blood Plasma Forecasted Market Size by Region
3.3.1 Global Blood Plasma Sales in Volume by Region (2024-2029)
3.3.2 Global Blood Plasma Sales in Value by Region (2024-2029)
3.3.3 Global Blood Plasma Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Blood Plasma by Application
4.1 Blood Plasma Market Segment by Application
4.1.1 Hospitals and Clinics
4.1.2 Research Laboratories
4.1.3 Academic Institutions
4.2 Global Blood Plasma Market Size by Application
4.2.1 Global Blood Plasma Market Size Overview by Application (2018-2029)
4.2.2 Global Blood Plasma Historic Market Size Review by Application (2018-2023)
4.2.3 Global Blood Plasma Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Blood Plasma Sales Breakdown by Application (2018-2023)
4.3.2 Europe Blood Plasma Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Blood Plasma Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Blood Plasma Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Blood Plasma Sales Breakdown by Application (2018-2023)
5 North America Blood Plasma by Country
5.1 North America Blood Plasma Historic Market Size by Country
5.1.1 North America Blood Plasma Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Blood Plasma Sales in Volume by Country (2018-2023)
5.1.3 North America Blood Plasma Sales in Value by Country (2018-2023)
5.2 North America Blood Plasma Forecasted Market Size by Country
5.2.1 North America Blood Plasma Sales in Volume by Country (2024-2029)
5.2.2 North America Blood Plasma Sales in Value by Country (2024-2029)
6 Europe Blood Plasma by Country
6.1 Europe Blood Plasma Historic Market Size by Country
6.1.1 Europe Blood Plasma Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Blood Plasma Sales in Volume by Country (2018-2023)
6.1.3 Europe Blood Plasma Sales in Value by Country (2018-2023)
6.2 Europe Blood Plasma Forecasted Market Size by Country
6.2.1 Europe Blood Plasma Sales in Volume by Country (2024-2029)
6.2.2 Europe Blood Plasma Sales in Value by Country (2024-2029)
7 Asia-Pacific Blood Plasma by Region
7.1 Asia-Pacific Blood Plasma Historic Market Size by Region
7.1.1 Asia-Pacific Blood Plasma Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Blood Plasma Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Blood Plasma Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Blood Plasma Forecasted Market Size by Region
7.2.1 Asia-Pacific Blood Plasma Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Blood Plasma Sales in Value by Region (2024-2029)
8 Latin America Blood Plasma by Country
8.1 Latin America Blood Plasma Historic Market Size by Country
8.1.1 Latin America Blood Plasma Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Blood Plasma Sales in Volume by Country (2018-2023)
8.1.3 Latin America Blood Plasma Sales in Value by Country (2018-2023)
8.2 Latin America Blood Plasma Forecasted Market Size by Country
8.2.1 Latin America Blood Plasma Sales in Volume by Country (2024-2029)
8.2.2 Latin America Blood Plasma Sales in Value by Country (2024-2029)
9 Middle East and Africa Blood Plasma by Country
9.1 Middle East and Africa Blood Plasma Historic Market Size by Country
9.1.1 Middle East and Africa Blood Plasma Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Blood Plasma Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Blood Plasma Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Blood Plasma Forecasted Market Size by Country
9.2.1 Middle East and Africa Blood Plasma Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Blood Plasma Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Baxter International
10.1.1 Baxter International Company Information
10.1.2 Baxter International Introduction and Business Overview
10.1.3 Baxter International Blood Plasma Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Baxter International Blood Plasma Products Offered
10.1.5 Baxter International Recent Development
10.2 CSL
10.2.1 CSL Company Information
10.2.2 CSL Introduction and Business Overview
10.2.3 CSL Blood Plasma Sales, Revenue and Gross Margin (2018-2023)
10.2.4 CSL Blood Plasma Products Offered
10.2.5 CSL Recent Development
10.3 Grifols
10.3.1 Grifols Company Information
10.3.2 Grifols Introduction and Business Overview
10.3.3 Grifols Blood Plasma Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Grifols Blood Plasma Products Offered
10.3.5 Grifols Recent Development
10.4 Octapharma
10.4.1 Octapharma Company Information
10.4.2 Octapharma Introduction and Business Overview
10.4.3 Octapharma Blood Plasma Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Octapharma Blood Plasma Products Offered
10.4.5 Octapharma Recent Development
10.5 ADMA Biologics
10.5.1 ADMA Biologics Company Information
10.5.2 ADMA Biologics Introduction and Business Overview
10.5.3 ADMA Biologics Blood Plasma Sales, Revenue and Gross Margin (2018-2023)
10.5.4 ADMA Biologics Blood Plasma Products Offered
10.5.5 ADMA Biologics Recent Development
10.6 Cerus Corp
10.6.1 Cerus Corp Company Information
10.6.2 Cerus Corp Introduction and Business Overview
10.6.3 Cerus Corp Blood Plasma Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Cerus Corp Blood Plasma Products Offered
10.6.5 Cerus Corp Recent Development
10.7 Sanquin
10.7.1 Sanquin Company Information
10.7.2 Sanquin Introduction and Business Overview
10.7.3 Sanquin Blood Plasma Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Sanquin Blood Plasma Products Offered
10.7.5 Sanquin Recent Development
10.8 Shanghai Raas
10.8.1 Shanghai Raas Company Information
10.8.2 Shanghai Raas Introduction and Business Overview
10.8.3 Shanghai Raas Blood Plasma Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Shanghai Raas Blood Plasma Products Offered
10.8.5 Shanghai Raas Recent Development
10.9 TCS Biosciences
10.9.1 TCS Biosciences Company Information
10.9.2 TCS Biosciences Introduction and Business Overview
10.9.3 TCS Biosciences Blood Plasma Sales, Revenue and Gross Margin (2018-2023)
10.9.4 TCS Biosciences Blood Plasma Products Offered
10.9.5 TCS Biosciences Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Blood Plasma Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Blood Plasma Industrial Chain Analysis
11.4 Blood Plasma Market Dynamics
11.4.1 Blood Plasma Industry Trends
11.4.2 Blood Plasma Market Drivers
11.4.3 Blood Plasma Market Challenges
11.4.4 Blood Plasma Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Blood Plasma Distributors
12.3 Blood Plasma Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
